These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2611943)

  • 1. Reaction of (R)-(-)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)platinum( II) with guanosine.
    Itoh M; Murata H; Honda M; Watanabe Y; Ochi K
    Chem Pharm Bull (Tokyo); 1989 Oct; 37(10):2825-7. PubMed ID: 2611943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The new anticancer drug [(2R)-aminomethylpyrrolidine](1, 1-cyclobutanedicarboxylato)platinum(II) and its toxic S enantiomer do interact differently with nucleic acids.
    Bloemink MJ; Pérez JM; Heetebrij RJ; Reedijk J
    J Biol Inorg Chem; 1999 Oct; 4(5):554-67. PubMed ID: 10550684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Water-soluble third generation antitumor platinum complexes, [2,2-bis (aminomethyl)-1,3-propanediol-N,N']-[1,1-cyclobutanedicarboxylato (2-)-O,O']platinum(II) and [1,1-cyclobutanedicarboxylato(2-)-O,O'] [tetrahydro-4H-pyran-4,4-dimethanamine-N,N']platinum(II).
    Bitha P; Carvajal SG; Citarella RV; Child RG; Delos Santos EF; Dunne TS; Durr FE; Hlavka JJ; Lang SA; Lindsay HL
    J Med Chem; 1989 Aug; 32(8):2015-20. PubMed ID: 2754720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interactions of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) and related compounds with deoxyribonucleic acid.
    Morikawa K; Matsumoto T; Matsuoka Y; Koizumi K
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):212-9. PubMed ID: 1576676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of platinum complexes of 2-aminomethylpyrrolidine derivatives for use as carrier ligands and their antitumor activities.
    Morikawa K; Honda M; Endoh K; Matsumoto T; Akamatsu K; Mitsui H; Koizumi M
    Chem Pharm Bull (Tokyo); 1990 Apr; 38(4):930-5. PubMed ID: 2379286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicological and tumoricidal evaluations of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)platinum( II) monohydrate, in rats.
    Akamatsu K; Endo K; Matsumoto T; Morikawa K; Koizumi M; Koizumi K; Mitsui H
    Jpn J Cancer Res; 1991 Jun; 82(6):724-31. PubMed ID: 1906857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor activity of a new platinum complex, (R)-(-)-2-aminomethylpyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II), against cisdiamminedichloroplatinum (II)-resistant murine leukemia cell line].
    Akamatsu K; Endo K; Matsumoto T; Kamisango K; Morikawa K; Koizumi M; Mitsui H; Koizumi K; Matsuno T
    Gan To Kagaku Ryoho; 1990 Jan; 17(1):73-8. PubMed ID: 2404458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the antitumour effects and nephrotoxicity-inducing activities of two new platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)-platinum (II) monohydrate, and its enantiomeric isomer.
    Matsumoto T; Endoh K; Akamatsu K; Kamisango K; Mitsui H; Koizumi K; Morikawa K; Koizumi M; Matsuno T
    Br J Cancer; 1991 Jul; 64(1):41-6. PubMed ID: 1854626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato) platinum (II) monohydrate with DNA as determined by a nitrocellulose filter binding assay].
    Matsumoto T; Akamatsu K; Mitsui H; Koizumi K
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):253-5. PubMed ID: 1736839
    [No Abstract]   [Full Text] [Related]  

  • 11. Insight into the antitumor actions of sterically hindered platinum(ii) complexes by a combination of STD NMR and LCMS techniques.
    Wang Z; Fang L; Zhao J; Gou S
    Metallomics; 2020 Mar; 12(3):427-434. PubMed ID: 32022072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR studies of an oligonucleotide with an unusual structure induced by platinum anti-cancer drugs.
    Kline TP; Marzilli LG; Live D; Zon G
    Biochem Pharmacol; 1990 Jul; 40(1):97-113. PubMed ID: 2372316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antitumor mechanism of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++) platinum(II).
    Akamatsu K; Endo K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1991; 11(1):151-5. PubMed ID: 2018348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, antitumor activity, and nephrotoxicity of the optical isomers of 2-aminomethylpyrrolidine(1,1-cyclobutane-dicarboxylato)platinum(II).
    Morikawa K; Honda M; Endoh K; Matsumoto T; Akamatsu K; Mitsui H; Koizumi M
    J Pharm Sci; 1991 Sep; 80(9):837-42. PubMed ID: 1800705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of treatment schedule of an antitumor platinum complex, DWA2114R, on the antitumor activity].
    Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):223-8. PubMed ID: 1736834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation and structure of reaction products of cis-PtCl2(NH3)2 with d(ApG) and/or d(GpA) in di-, tri- and penta-nucleotides. Preference for GpA chelation over ApG chelation.
    Dijt FJ; Chottard JC; Girault JP; Reedijk J
    Eur J Biochem; 1989 Feb; 179(2):335-44. PubMed ID: 2537207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemistry of HIV-1 virucidal Pt complexes having neglected bidentate sp2 N-donor carrier ligands with linked triazine and pyridine rings. synthesis, NMR spectral features, structure, and reaction with guanosine.
    Maheshwari V; Bhattacharyya D; Fronczek FR; Marzilli PA; Marzilli LG
    Inorg Chem; 2006 Sep; 45(18):7182-90. PubMed ID: 16933918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent antitumour activity of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) against advanced L1210 leukaemia in mice.
    Akamatsu K; Endo K; Matsumoto T; Kamisango K; Morikawa K; Koizumi M; Koizumi K
    Br J Cancer; 1992 Nov; 66(5):827-32. PubMed ID: 1419625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence-dependent termination of mammalian DNA polymerase reaction by a new platinum compound, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutane-dicarboxylato)-2-plati num(II) monohydrate).
    Iwata M; Izuta S; Suzuki M; Kojima K; Furuhashi Y; Tomoda Y; Yoshida S
    Jpn J Cancer Res; 1991 Apr; 82(4):433-9. PubMed ID: 1904423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells.
    Fujiwara Y; Nakamura M; Yokoo S
    Br J Cancer; 1993 Jun; 67(6):1285-92. PubMed ID: 8512813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.